Phenotyping the Use of Cangrelor in Percutaneous Coronary Interventions. [PDF]
Pyrpyris N+9 more
europepmc +1 more source
Comparing efficacy and safety of low-dose versus standard-dose antiplatelet therapy in stroke patients: a meta-analysis. [PDF]
Ren Z+8 more
europepmc +1 more source
CYP2C19 Genotype-Guided Antiplatelet Therapy and Clinical Outcomes in Patients Undergoing a Neurointerventional Procedure. [PDF]
Tunehag KR+5 more
europepmc +1 more source
Ultrashort Versus 1-Year Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: Meta-analysis of Randomized Controlled Trials. [PDF]
Dodoo SN+12 more
europepmc +1 more source
Clopidogrel combined with rivaroxaban in peripheral artery disease after revascularization. [PDF]
Lu M, Li J, Ni H, Qiao T, Wang B.
europepmc +1 more source
Optimal antithrombotic therapy after transcatheter aortic valve replacement: a comprehensive review. [PDF]
Thanh NVT, Hong MK, Ko YG.
europepmc +1 more source
New options for cilostazol-based dual antiplatelet therapy for ischaemic stroke prevention in East Asian populations: a systematic review and meta-analysis. [PDF]
Wang X+11 more
europepmc +1 more source
Effects of different antiplatelet therapy drugs on platelet activation and platelet-leukocyte aggregate formation in early septic ARDS. [PDF]
Wang L, Mi LY, Chen XY, He HW, Long Y.
europepmc +1 more source
Comparison of 1-Year Clinical Outcomes Between Ticagrelor Versus Clopidogrel in Type 2 Diabetes Patients After Implantation of Small Diameter Stents. [PDF]
Algazzar AS+8 more
europepmc +1 more source
Potent P2Y12 inhibitors in patients with acute myocardial infarction and cardiogenic shock. [PDF]
Jo J+32 more
europepmc +1 more source